Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.11.2021 | Case report

Antineoplastics/immunosuppressants/emapalumab

Reactivation of Epstein-Barr virus infection, Clostridium difficile colitis and lack of efficacy

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Fußnoten
1
Country of occurrence, reporter country and primary source country not stated. Abstract presented at CHEST 2021 Annual Meeting Abstracts. Also, cardiac tamponade and metastatic gastrointestinal carcinoma were no where mentioned in the case presentation. Therefore, could not be related to the patient.
 
Metadaten
Titel
Antineoplastics/immunosuppressants/emapalumab
Reactivation of Epstein-Barr virus infection, Clostridium difficile colitis and lack of efficacy
Publikationsdatum
01.11.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-04892-y

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Vancomycin

Case report

Diazepam

Case report

Bupivacaine

Case report

Prednisolone